Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1233247.RAu-HvXnXKCS1mQ-YGdkprKQv0hgMMdL9qoI4intKC-m4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1233247.RAu-HvXnXKCS1mQ-YGdkprKQv0hgMMdL9qoI4intKC-m4130_assertion type Assertion NP1233247.RAu-HvXnXKCS1mQ-YGdkprKQv0hgMMdL9qoI4intKC-m4130_head.
- NP1233247.RAu-HvXnXKCS1mQ-YGdkprKQv0hgMMdL9qoI4intKC-m4130_assertion description "[The present results indicated that LY294002 inhibits the malignant phenotype of OS cells via modulation of the PI3K/Akt/FASN signaling pathway in vitro and may be a new therapeutic strategy for the management of OS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1233247.RAu-HvXnXKCS1mQ-YGdkprKQv0hgMMdL9qoI4intKC-m4130_provenance.
- NP1233247.RAu-HvXnXKCS1mQ-YGdkprKQv0hgMMdL9qoI4intKC-m4130_assertion evidence source_evidence_literature NP1233247.RAu-HvXnXKCS1mQ-YGdkprKQv0hgMMdL9qoI4intKC-m4130_provenance.
- NP1233247.RAu-HvXnXKCS1mQ-YGdkprKQv0hgMMdL9qoI4intKC-m4130_assertion SIO_000772 25351625 NP1233247.RAu-HvXnXKCS1mQ-YGdkprKQv0hgMMdL9qoI4intKC-m4130_provenance.
- NP1233247.RAu-HvXnXKCS1mQ-YGdkprKQv0hgMMdL9qoI4intKC-m4130_assertion wasDerivedFrom befree-2016 NP1233247.RAu-HvXnXKCS1mQ-YGdkprKQv0hgMMdL9qoI4intKC-m4130_provenance.
- NP1233247.RAu-HvXnXKCS1mQ-YGdkprKQv0hgMMdL9qoI4intKC-m4130_assertion wasGeneratedBy ECO_0000203 NP1233247.RAu-HvXnXKCS1mQ-YGdkprKQv0hgMMdL9qoI4intKC-m4130_provenance.